Protalix BioTherapeutics, Inc. Indenture Agreements

6 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Third Supplemental Indenture, dated as of August 24, 2021, by and among Protalix BioTherapeutics, Inc., the guarantors party hereto and The Bank of New York Mellon Trust Company,...
Indenture Agreements
Protalix BioTherapeutics, Inc.
Biotechnology
NY
2021
Second Supplemental Indenture, dated as of November 27, 2017, by and among Protalix BioTherapeutics, Inc., the guarantors party hereto and The Bank of New York Mellon Trust...
Indenture Agreements
Protalix BioTherapeutics, Inc.
Biotechnology
NY
2017
FIRST SupplementalIndenture between PROTALIXBIOTHERAPEUTICS, INC., as Issuer, ANDEACH OF THE GUARANTORS PARTY HERETO, and TheBank of New York Mellon Trust CoMPANY, N.A., as...
Indenture Agreements
Protalix BioTherapeutics, Inc.
Biotechnology
NY
2017
Protalix BioTherapeutics, Inc. (Company) The Bank of New York Mellon Trust Company, N.A.,as Trustee (Trustee) 4.50% Convertible Senior Notes due 2022 INDENTURE Dated as of July...
Indenture Agreements
Protalix BioTherapeutics, Inc.
Biotechnology
NY
2017
PROTALIX BIOTHERAPEUTICS, INC. AS ISSUER AND EACH OF THE GUARANTORS PARTY HERETO 7.50% SENIOR SECURED CONVERTIBLE NOTESDUE 2021 INDENTURE DATED AS OF DECEMBER 7, 2016 THE BANK OF...
Indenture Agreements
Protalix BioTherapeutics, Inc.
Biotechnology
NY
2016
ProtalixBioTherapeutics, Inc. (Company) The Bankof New York Mellon Trust Company, N.A. (Trustee) 4.50%Convertible Senior Notes due 2018 INDENTURE Datedas of September 18, 2013
Indenture Agreements
Protalix BioTherapeutics, Inc.
Biotechnology
NY
2013